The mobile gamma cameras market size is projected to be worth US$ 59.5 billion in 2023. The market is likely to reach US$ 89.8 billion by 2033. The market is further expected to surge at a CAGR of 4.2% during the forecast period 2023 to 2033.
Key Market Trends and Highlights
| Attributes | Key Insights |
|---|---|
| Mobile Gamma Cameras Market Estimated Size in 2023 | US$ 59.5 billion |
| Projected Market Value in 2033 | US$ 89.8 billion |
| Value-based CAGR from 2023 to 2033 | 4.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for mobile gamma cameras rose at a 4.0% CAGR between 2018 and 2022. The global market for mobile gamma cameras is anticipated to grow at a moderate CAGR of 4.2% over the forecast period 2023 to 2033.
| Report Attribute | Details |
|---|---|
| Market Value in 2018 | US$ 48.1 billion |
| Market Value in 2022 | US$ 56.3 billion |
| CAGR from 2018 to 2022 | 4.0% |
The mobile gamma cameras market has witnessed significant changes in the transition from 2018 to 2022 to the forecast period from 2023 to 2033. During 2018 to 2022, the market experienced growth, due to factors such as driven by technological advancements, broader clinical adoption, and increasing healthcare investments globally.
Mobile gamma cameras found expanded applications in various medical fields, including cardiology, oncology, orthopedics, and neurology. The versatility of these devices contributed to their growing adoption. The rising incidence of chronic diseases, such as cardiovascular disorders and cancer, drove the demand for mobile gamma cameras for early diagnosis and treatment planning.
During 2023 to 2033, the market is projected to expand, owing to wider clinical adoption. Mobile gamma cameras are likely to be adopted in a broader range of clinical settings, including smaller clinics and outpatient facilities, due to their versatility and mobility. The integration of mobile gamma cameras with telemedicine and remote monitoring systems is expected to enhance patient care and enable real-time data sharing with healthcare professionals.
Mobile gamma cameras will play a vital role in the trend toward personalized medicine, facilitating targeted treatments based on individual patient characteristics and disease profiles. Artificial intelligence (AI) and machine learning applications in medical imaging will further improve the accuracy and speed of diagnosis with mobile gamma cameras.
Principal Consultant
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and China. These two countries are expected to lead the market through 2033.
Market Share in 2022
| The United States | 83.9% |
|---|---|
| China | 25.0% |
| India | 15.0% |
| Japan | 22.0% |
| The United Kingdom | 15.0% |
Forecast CAGRs from 2023 to 2033
| The United States | 4.1% |
|---|---|
| China | 4.1% |
| India | 4.0% |
| Japan | 4.1% |
| The United Kingdom | 3.7% |
The mobile gamma cameras market in the United States is expected to expand at a CAGR of 4.1% through 2033. The country held a market share of 83.9% in 2022. The United States has a high prevalence of chronic diseases, such as cancer and heart disease. The demand for diagnostic tools like mobile gamma cameras to detect and monitor these conditions continues to grow, as the population ages.
The United States is a hub for medical technology innovation. Ongoing advancements in mobile gamma camera technology, including improved image quality and reduced radiation exposure, are driving adoption in the country.
The United States has a well-developed healthcare infrastructure, which includes hospitals, clinics, and imaging centers. The infrastructure supports the deployment and use of mobile gamma cameras for diagnostics and treatment planning.
Mobile gamma cameras trends in China are taking a turn for the better. A 4.1% CAGR is forecast for the country from 2023 to 2033. The country held a market share of 25.0% in 2022.
China has been investing significantly in its healthcare infrastructure, leading to an increase in the number of healthcare facilities and diagnostic centers that require advanced imaging equipment like mobile gamma cameras.
Manufacturers are introducing more advanced and mobile-friendly gamma cameras with improved imaging capabilities, making them attractive to healthcare providers in China. The ongoing urbanization in China has led to increased healthcare facilities in urban areas, where the demand for diagnostic imaging equipment is higher.
Growing healthcare awareness among the Chinese population and increased education about the benefits of early diagnosis contribute to the demand for diagnostic imaging services. Private healthcare providers in China are also investing in advanced medical equipment, including mobile gamma cameras, to attract patients seeking high-quality healthcare services.
The mobile gamma cameras market in India is poised to expand at a CAGR of 4.0% through 2033. India has a significant burden of chronic and non-communicable diseases, including cancer, cardiovascular diseases, and neurological disorders. The rising incidence of these diseases drives the demand for advanced diagnostic tools, including mobile gamma cameras.
The Indian government has launched various healthcare initiatives to improve access to quality healthcare services. The initiatives can create a conducive environment for the adoption of advanced medical imaging technologies.
India is a popular destination for medical tourism. The availability of state-of-the-art medical equipment, including mobile gamma cameras, contributes to the country's attractiveness as a healthcare destination. The country held a market share of 15.0% in 2022.
The Japan’s mobile gamma cameras market is anticipated to expand at a CAGR of 4.1% through 2033. Continuous advancements in gamma camera technology have made them more compact, mobile, and efficient. The advancements make mobile gamma cameras an attractive option for healthcare providers in Japan.
Both public and private healthcare providers in Japan are investing in state-of-the-art medical equipment to offer high-quality healthcare services. Mobile gamma cameras are essential in emergency medical services for rapid and accurate diagnosis of conditions like myocardial infarction. The integration of gamma cameras in ambulances is gaining traction.
Japan is known for its research and development activities in medical technology. Local manufacturers are developing innovative gamma camera systems, creating growth opportunities. Collaborations between Japanese healthcare institutions and international medical equipment manufacturers promote the adoption of advanced gamma camera systems. The country held a market share of 22.0% in 2022.
The mobile gamma cameras market in the United Kingdom is anticipated to expand at a CAGR of 3.7% through 2033. The United K has a rapidly aging population, leading to an increased prevalence of age-related health conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders. Mobile gamma cameras play a crucial role in the diagnosis and management of these conditions, driving demand.
The National Health Service (NHS) is the publicly funded healthcare system in the United Kingdom, providing healthcare services to the majority of the population. The NHS's commitment to improving healthcare services and access to advanced diagnostic tools supports the growth of the mobile gamma cameras Market.
The country has embraced telemedicine and remote healthcare services, especially in rural and underserved areas. Mobile gamma cameras can be deployed in remote settings for diagnostic imaging and teleconsultations. The country held a market share of 15.0% in 2022.
The below table highlights how single head mobile gamma camera segment is projected to lead the market in terms of product type, and held a market share of 62.5% in 2022.
The hospitals segment of end-user is likely to spearhead sales, and held a market share of 41.0% in 2022.
| Category | Market Share in 2022 |
|---|---|
| Single Head Mobile Gamma Camera | 62.5% |
| Hospitals | 41.0% |
Based on product type, the single head mobile gamma camera segment is expected to continue dominating the mobile gamma cameras industry. The segment held a market share of 62.5% in 2022.
Single head mobile gamma cameras are typically more affordable than their multi-headed counterparts. The cost-effectiveness makes them an attractive option for healthcare facilities looking to invest in diagnostic imaging equipment without a significant financial burden.
Single head mobile gamma cameras are highly portable and easy to maneuver within healthcare settings. Their compact design allows for flexibility in positioning, making them suitable for various clinical environments, including smaller examination rooms.
The compact and less intimidating design of single head mobile gamma cameras can contribute to improved patient comfort and cooperation during imaging procedures. Patients may find these cameras less intimidating than larger, multi-headed systems.
Based on end-user, the hospitals segment is expected to continue dominating the mobile gamma cameras industry. The segment held a market share of 41.0% in 2022.
Hospitals are the primary healthcare institutions for diagnosing and treating a wide range of medical conditions, including cancer, cardiovascular diseases, and neurological disorders. The need for advanced diagnostic imaging equipment like mobile gamma cameras is rising, along with an increase in the patient admission rates.
Hospitals provide comprehensive medical care and are often equipped with various specialized departments, such as oncology and cardiology. Mobile gamma cameras are essential tools in these departments for diagnosing and monitoring diseases and conditions.
Hospitals offer emergency services, and mobile gamma cameras can be crucial in time-sensitive situations for rapid diagnosis and treatment planning, particularly in cases of trauma and acute illnesses.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Collaborations between manufacturers, end-users, and research institutions can lead to the development of innovative mobile gamma camera-based solutions for emerging applications.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
| Attribute | Details |
|---|---|
| Estimated Market Size in 2023 | US$ 59.5 billion |
| Projected Market Valuation in 2033 | US$ 87.8 billion |
| Value-based CAGR 2023 to 2033 | 4.2% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value in US$ billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The mobile gamma cameras market is expected to reach US$ 59.5 billion in 2023.
The market for mobile gamma cameras is set to expand by a CAGR of 4.2% by 2033.
The mobile gamma cameras industry is forecast to reach US$ 89.8 billion by 2033.
The United States is likely to be the top performing market, and to expand at a CAGR of 4.1% through 2033.
Single Head segment is preferred, and held a market share of 62.5% in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Single Head Mobile Gamma Camera
5.3.2. Double Head Mobile Gamma Camera
5.3.3. Triple Head Mobile Gamma Camera
5.3.4. Hand Held Mobile Gamma Camera
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
6.3.1. Cardiac Imaging
6.3.2. Breast Imaging
6.3.3. Hepatobiliary Imaging
6.3.4. GI Imaging
6.3.5. Renal Imaging
6.3.6. Brain Imaging
6.3.7. Others
6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-user, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-user, 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Cancer Research Institutes
7.3.4. Specialized Clinics
7.4. Y-o-Y Growth Trend Analysis By End-user, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-user, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Indication
9.2.4. By End-user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Indication
9.3.4. By End-user
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Indication
10.2.4. By End-user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Indication
10.3.4. By End-user
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product Type
11.2.3. By Indication
11.2.4. By End-user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Indication
11.3.4. By End-user
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product Type
12.2.3. By Indication
12.2.4. By End-user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Indication
12.3.4. By End-user
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product Type
13.2.3. By Indication
13.2.4. By End-user
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Indication
13.3.4. By End-user
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Indication
14.2.4. By End-user
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Indication
14.3.4. By End-user
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Indication
15.2.4. By End-user
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Indication
15.3.4. By End-user
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Indication
16.1.2.3. By End-user
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Indication
16.2.2.3. By End-user
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Indication
16.3.2.3. By End-user
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Indication
16.4.2.3. By End-user
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Indication
16.5.2.3. By End-user
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Indication
16.6.2.3. By End-user
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Indication
16.7.2.3. By End-user
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Indication
16.8.2.3. By End-user
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Indication
16.9.2.3. By End-user
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Indication
16.10.2.3. By End-user
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Indication
16.11.2.3. By End-user
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Indication
16.12.2.3. By End-user
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Indication
16.13.2.3. By End-user
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Indication
16.14.2.3. By End-user
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Indication
16.15.2.3. By End-user
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Indication
16.16.2.3. By End-user
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Indication
16.17.2.3. By End-user
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Indication
16.18.2.3. By End-user
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Indication
16.19.2.3. By End-user
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Indication
16.20.2.3. By End-user
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Indication
16.21.2.3. By End-user
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Indication
16.22.2.3. By End-user
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Indication
16.23.2.3. By End-user
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Indication
17.3.4. By End-user
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Digirad Corporation
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. DDD-Diagnostic A/S
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Dilon Technologies, Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Spectrum Dynamics Medical
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. GAEDE Medizinsysteme GmbH
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Beijing Hamamatsu Photon Techniques Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. MIE America
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Mediso
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. CLERAD
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. CardiArc
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Mobile Gamma Cameras Market
